Regulation of B cell growth and differentiation via CD21 and CD40

被引:22
作者
Axcrona, K [1 ]
Gray, D [1 ]
Leanderson, T [1 ]
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT IMMUNOL,LONDON W12 0HS,ENGLAND
基金
英国惠康基金;
关键词
B cell; CD21; CD40;
D O I
10.1002/eji.1830260936
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Stimulation in vitro of murine splenic B cells by lipopolysaccharide, anti-kappa Sepharose, anti-CD40 or allo-reactive T helper cells all up-regulated CD21 and CD23 surface expression. Neither anti-CD21 nor anti-CD23 antibodies induced B cell growth or differentiation when added in soluble form or coupled to Sepharose. However, anti-CD40-stimulated B cells showed increased proliferation in the presence of anti-CD21 antibodies coupled to Sepharose; co-stimulation via CD21 also induced differentiation to immunoglobulin secretion in a fraction of anti-CD40-stimulated B cells. Furthermore, anti-CD40 antibodies inhibited differentiation to immunoglobulin secretion induced by lipopolysaccharide and, hence, appears to be a dominant negative signal for B cell differentiation.
引用
收藏
页码:2203 / 2207
页数:5
相关论文
共 31 条
  • [1] INHIBITION OF MITOGENIC STIMULATION OF MOUSE LYMPHOCYTES BY ANTI-MOUSE IMMUNOGLOBULIN ANTIBODIES .1. MODE OF ACTION
    ANDERSSON, J
    BULLOCK, WW
    MELCHERS, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1974, 4 (11) : 715 - 722
  • [2] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    [J]. CELL, 1993, 72 (02) : 291 - 300
  • [3] BONNEFOY JY, 1993, EUR J IMMUNOL, V23, P969
  • [4] ACTIVATION OF HUMAN B-CELLS MEDIATED THROUGH 2 DISTINCT CELL-SURFACE DIFFERENTIATION ANTIGENS, BP35 AND BP50
    CLARK, EA
    LEDBETTER, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4494 - 4498
  • [5] EPSTEIN-BARR-VIRUS COMPLEMENT C3D RECEPTOR IS AN INTERFERON-ALPHA RECEPTOR
    DELCAYRE, AX
    SALAS, F
    MATHUR, S
    KOVATS, K
    LOTZ, M
    LERNHARDT, W
    [J]. EMBO JOURNAL, 1991, 10 (04) : 919 - 926
  • [6] C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
    Dempsey, PW
    Allison, MED
    Akkaraju, S
    Goodnow, CC
    Fearon, DT
    [J]. SCIENCE, 1996, 271 (5247) : 348 - 350
  • [7] ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE
    ENGEL, P
    ZHOU, LJ
    ORD, DC
    SATO, S
    KOLLER, B
    TEDDER, TF
    [J]. IMMUNITY, 1995, 3 (01) : 39 - 50
  • [8] FINGEROTH JD, 1981, P NATL ACAD SCI USA, P4510
  • [9] A SOLUBLE FORM OF TRAP (CD40 LIGAND) IS RAPIDLY RELEASED AFTER T-CELL ACTIVATION
    GRAF, D
    MULLER, S
    KORTHAUER, U
    VANKOOTEN, C
    WEISE, C
    KROCZEK, RA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) : 1749 - 1754
  • [10] GRAMMER AC, 1995, J IMMUNOL, V154, P4996